Noetik co-founders: CEO Ron Alfa (L) and CSO Jacob Rinaldi
September 7, 2023 06:30 AM EDT
Financing
Startups

Ex­clu­sive: Two ex-Re­cur­sion lead­ers start Noetik in a bid to fix the bro­ken fun­nel in can­cer drug re­search

Andrew Dunn

Senior Biopharma Correspondent

Two for­mer lead­ers of Re­cur­sion Phar­ma­ceu­ti­cals have start­ed their own biotech start­up, hop­ing to bring a sim­i­lar da­ta-ob­sessed men­tal­i­ty to can­cer re­search.

The San Fran­cis­co …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Mer­ck’s long-await­ed obe­si­ty move is an oral GLP-1 from Chi­na

Ma­jor PBM re­forms fea­ture in Con­gress' year-end spend­ing bill

What Trump’s FTC picks mean for bio­phar­ma deal­mak­ing and PBMs

Up­dat­ed: Ver­tex’s non-opi­oid pill dis­ap­points in mid-stage chron­ic pain study

A service from the Financial Times